Verona Pharma ADR (VRNA) Q2 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.8
-0.53
-0.27
0

Details

Expected EPS
-0.29
Actual EPS
-0.8
Surprise EPS
-0.51
Surprise Percent
+175.86%

Description

Verona Pharma ADR (VRNA) has reported earnings of -0.8 per share for Q2 2024.

0 Comments

Share your thoughts